BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19578105)

  • 1. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients.
    Zhou WJ; Yang CD
    Lupus; 2009 Aug; 18(9):807-12. PubMed ID: 19578105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus and infections: a retrospective study in Saudis.
    Al-Rayes H; Al-Swailem R; Arfin M; Sobki S; Rizvi S; Tariq M
    Lupus; 2007; 16(9):755-63. PubMed ID: 17728372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review.
    Chen HS; Tsai WP; Leu HS; Ho HH; Liou LB
    Rheumatology (Oxford); 2007 Mar; 46(3):539-44. PubMed ID: 17043051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.
    Petri M; Genovese M
    J Rheumatol; 1992 Oct; 19(10):1559-65. PubMed ID: 1464868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients.
    Duffy KN; Duffy CM; Gladman DD
    J Rheumatol; 1991 Aug; 18(8):1180-4. PubMed ID: 1941820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections in systemic lupus erythematosus.
    Oh HM; Chng HH; Boey ML; Feng PH
    Singapore Med J; 1993 Oct; 34(5):406-8. PubMed ID: 8153686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.
    Kwok SK; Ju JH; Cho CS; Kim HY; Park SH
    Lupus; 2009 Jan; 18(1):16-21. PubMed ID: 19074164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system infections in patients with systemic lupus erythematosus.
    Hung JJ; Ou LS; Lee WI; Huang JL
    J Rheumatol; 2005 Jan; 32(1):40-3. PubMed ID: 15630722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus.
    Mok MY; Wong SS; Chan TM; Fong DY; Wong WS; Lau CS
    Rheumatology (Oxford); 2007 Feb; 46(2):280-4. PubMed ID: 16861709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.
    Rovin BH; Tang Y; Sun J; Nagaraja HN; Hackshaw KV; Gray L; Rice R; Birmingham DJ; Yu CY; Spetie DN; Aziz A; Hebert LA
    Kidney Int; 2005 Aug; 68(2):747-59. PubMed ID: 16014052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteomyelitis in patients with systemic lupus erythematosus.
    Wu KC; Yao TC; Yeh KW; Huang JL
    J Rheumatol; 2004 Jul; 31(7):1340-3. PubMed ID: 15229953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus.
    Papo T; Andre MH; Amoura Z; Lortholary O; Tribout B; Guillevin L; Piette JC
    J Rheumatol; 1999 Apr; 26(4):927-30. PubMed ID: 10229419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin in systemic lupus erythematosus.
    Pauzner R; Urowitz MB; Gladman DD; Gough JM
    J Rheumatol; 1994 Nov; 21(11):2064-7. PubMed ID: 7869311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody.
    Kwok SK; Seo SH; Ju JH; Park KS; Yoon CH; Kim WU; Min JK; Park SH; Cho CS; Kim HY
    Lupus; 2007; 16(10):803-9. PubMed ID: 17895303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.
    Jeong SJ; Choi H; Lee HS; Han SH; Chin BS; Baek JH; Kim CO; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2009; 41(4):268-74. PubMed ID: 19172435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.